Carvacrol: An In Silico Approach of a Candidate Drug on HER2, PI3Kα, mTOR, hER-α, PR, and EGFR Receptors in the Breast Cancer.
Herrera-Calderon O, Yepes-Pérez AF, Quintero-Saumeth J, Rojas-Armas JP, Palomino-Pacheco M, Ortiz-Sánchez JM, Cieza-Macedo EC, Arroyo-Acevedo JL, Figueroa-Salvador L, Peña-Rojas G, Andía-Ayme V.
Herrera-Calderon O, et al. Among authors: rojas armas jp.
Evid Based Complement Alternat Med. 2020 Oct 26;2020:8830665. doi: 10.1155/2020/8830665. eCollection 2020.
Evid Based Complement Alternat Med. 2020.
PMID: 33163084
Free PMC article.